Premaxo 80mg Injection Vial 2 ml

babies: nil pregnancy: it may be unsafe to use during pregnancy. there are limited studies in humans and animal studies showing that the medication may cause harmful effects on the developing baby. lactating mothers: it is safe to use during breastfeeding if prescribed by a doctor.
human studies show that the drug does not pass into breast milk and is not harmful to the baby. alcohol: it is unsafe to consume alcohol while taking this medication. driving: it may affect your ability to drive as it may cause side effects such as dizziness, vertigo, visual disturbances and fatigue. kidney: it is safe to use in patients with kidney disease if prescribed by the doctor. dose adjustment is not needed. liver: consult your doctor before using this medication..

nausea sweating edema (swelling) thinning of skin increased risk of infection reduction in bone density weight gain mood changes upset stomach behavioral changes.

premaxo injection is a corticosteroid used to treat rheumatoid arthritis, asthma, allergic conditions, systemic lupus erythematosus and eye and skin disorders; it works by reducing swelling and redness and by changing the way the immune system works..

consult your doctor immediately if you missed the dose of premaxo injection..

• premaxo injection is prescribed to treat rheumatoid arthritis, asthma, allergic conditions, systemic lupus erythematosus, and eye and skin disorders. • avoid vaccination during premaxo therapy. • this medication may cause thinning of the skin, impaired wound healing, fluid retention, decreased body growth, peptic ulcer disease, muscle weakness, cataract, depression, euphoria, congestive heart failure, or seizure. consult your doctor if these effects worsen your condition. • inform your doctor if you notice any symptoms of infections, adrenocortical insufficiency or hypocortisolism. • inform your doctor if you find any abnormalities in your blood glucose levels as it may cause hyperglycemia..

• premaxo + desmopressin: concurrent use of these medications may result in an increased risk of severe hyponatremia. • premaxo + rotavirus vaccine: concurrent use of these medications may result in an increased risk of infection by the live vaccine. • premaxo + nsaids: concurrent use of these medications may increase the risk of gastrointestinal ulcer or bleeding. • premaxo + aldesleukin: concurrent use of these medications may result in reduced antitumor effectiveness. • premaxo + selected fluoroquinolones: concurrent use of these medications may result in an increased risk of tendon rupture. • premaxo + bemiparin: concurrent use of these medications may result in an increased risk of bleeding. • premaxo + telaprevir: concurrent use of these medications may result in increased premaxo plasma concentrations. • premaxo + voriconazole: concurrent use of these medications may result in increased premaxo exposure. • premaxo + acenocoumarol: concurrent use of these medications may result in an increased risk of bleeding or diminished effects of acenocoumarol. • premaxo + aspirin: concurrent use of these medications may result in an increased risk of gastrointestinal ulceration and sub-therapeutic aspirin serum concentrations. • premaxo + atazanavir/carbamazepine: concurrent use of these medications may increase the risk of premaxo side effects. • premaxo + auranofin: concurrent use of these medications may increase the risk of auranofin-related adverse effects. • premaxo + cyclosporine: concurrent use of these medications may result in cyclosporine toxicity and steroid excess. • premaxo + diltiazem: concurrent use of these medications may result in increased premaxo plasma concentrations and enhanced adrenal-suppressant effects. • premaxo + tuberculin: concurrent use of these medications may result in decreased reactivity to tuberculin..